Explore how and why we decide what drugs and treatments should be funded
Healthcare systems around the world are increasingly under pressure to fund new drugs, treatments and other healthcare interventions.
On this course, you’ll learn how health outcome measuring can help us to make more informed decisions about where to spend our limited healthcare budgets.
You’ll find out how patient-reported outcome measures (PROMs) and quality-adjusted life years (QALYs) are developed and calculated, and learn how they can be used to compare treatment benefits in practice.
What topics will you cover?
The course focuses on two different types of measures, asking how they’re developed and calculated, and how they’re used by decision makers in practice:
Patient Reported Outcome Measures (PROMs): which are measures completed by the patients themselves, about their health, symptoms, functioning, well-being or satisfaction with treatment.
Quality Adjusted Life Years (QALYs): which compare the benefits of different treatment options, based on the quality and quantity of life they yield.
When would you like to start?
Start straight away and learn at your own pace. If the course hasn’t started yet you’ll see the future date listed below.
Who is the course for?
This course is designed for anyone interested in how and why choices about drugs and treatments have been made.
It is ideal learning for anyone considering a career in healthcare, local decision-making or academia.
If you wish to take your learning further, the University of Sheffield’s other Masters degrees and short courses address areas such as health economics, public health and international healthcare technology assessment.
You can find out more about this subject in Dr Katherine Stevens’ post for the FutureLearn blog: “How do we make decisions in healthcare about which drugs and treatments to fund?.
Who developed the course?
The University of Sheffield
The University of Sheffield is one of the world’s top 100 universities with a reputation for teaching and research excellence.